Flavio Finotello

CEO, Chairman & Chief Commercial Officer at Cormay Diagnostics

Warsaw, Mazowieckie, Poland

About

Executive and Management Board professional currently leading an amazing team aspiring to improve the health of people all over the world through the development of In-Vitro Diagnostic solutions for earliest possible detection, treatment and monitoring of a person’s overall health. Proven track record in global and regional roles delivering long term sustainable growth and business turnarounds with market leading multinationals The Linde Group (based in Europe), The BOC Group (based in Australia), Varian (since acquired by Agilent Technologies) and ICI Chemicals (since acquired by AkzoNobel) across diverse industries including Healthcare, IVD, Industrial & Specialty Gases, Refrigerants, Life Sciences, Specialty Chemicals and Leading Edge Technologies. Recognized for strong and passionate leadership, unwavering credibility and integrity, problem solving, creativity in ambiguous situations, cross-cultural and cross-functional diversity & inclusion. Promotes innovation, technology, performance and service as key drivers of customer value and satisfaction. Empowers people by fostering a culture of creativity, transparency, accountability and collaboration. Grooms the next generation to drive sustainable growth.

Experience

  • CEO, Chairman & Chief Commercial Officer Cormay Diagnostics at Cormay Diagnostics
    2017 - Present · 9 yrs 6 mos

    Cormay Diagnostics, a publicly listed company, develops in-vitro diagnostic solutions that combine innovative analyzers with high-performance reagents to clinical laboratories and hospitals worldwide. Reporting to the Supervisory Board, Responsibilities include; - Delivering Shareholder Value - Full P&L - Vision & Strategy - Stretching Sales & Profit Budgets - Sales Channel Performance: Subsidiaries & Distributors in > 100 Countries - Implementation & Compliance to New IVDR Regulations - Corporate Branding & Marketing Communications - Leading Technology & Innovation (New Product Development) - Knowledge Transfer & Organizational Learning - Strategic Partnerships (OEMs, Key Accounts, Strategic Alliances) - Creation of a Differentiated & Valued Product & Service Offer - Leading the Customer Satisfaction Experience - Leading Operational Excellence Key Achievements: Delivered Transformative Performance within 3 Years  Record High Sales following a Decade of Decline  Sustainability with > 10% CAGR 2020 - 2025  Margin Improvement by > 10% with no Customer Losses  +ve EBITDA following a Decade of Losses Developed a 5 Year Plan comprising:  A Technology Roadmap with Goals to: • Launch > 300 New IVD Products to 2024 • Modernize & Expand Existing Clinical Chemistry & Hematology Product Portfolios, & • Expand into Multiple New IVD Segments including Immunochemistry, Coagulology, Urinalysis, Molecular Diagnostics, Diabetes, POCT & Veterinary  Knowledge Transfer by Recruiting Talent from Leading Global Brands  Creation of Customer Valued PSOs Differentiated by Innovation, Technology, Quality & Performance  Rebranding Cormay Diagnostics into an Internationally Recognized IVD brand.  Forging New Strategic Partnerships  Re-engineering the Order-to-Delivery Promise to Enhance Customer Experience & Satisfaction  Strengthening Distribution Channels through Aggressive New Distributor Program & Knowledge Transfer

  • Head of Specialty Gases, Chemicals, Refrigerants, Helium & Electronics at The Linde Group
    2005 - 2017 · 12 yrs

    The Linde Group is Industrial Gas Market Leader with over 100,000 employees located in 150 countries & 30 billion € p.a turnover. It’s largest region, REE&ME, covers 10 time zones and over 30 countries including Russia & ex-CIS countries, Central Eastern Europe, Eastern Europe, the Balkans, South Eastern Europe, Turkey & the Middle East. Reporting to the Regional Head of Sales & Marketing, Key Responsibilities included: - P&L for 5 Business Units, Specialty Gases, Chemicals, Refrigerants, Helium & Electronics - Vision & Strategy - Setting Stretching Sales & Profit Budgets - Driving Growth through M&A, Capital Investments, New Product Launches & New Markets - Aligning Global, Regional & Country Plans - Building & Leading High Performing Cross Functional, Cross Cultural Teams - Price, Key Accounts, Sales Channels, Supply Chain & Tender Negotiations Key Achievements:  Delivered Transformational Performance • Grew Sales from 20m to 150m €'s in10 Years • Accounted for 15% of Regional Turnover & 25% of Profit • Became Region's Top Performer with > 10% CAGR over 10 Years • Delivered Market Leadership with > 20% p.a. Growth in Strategic Markets (Russia, Turkey, the Middle East) • Delivered > 10% p.a. Growth in Mature Markets • Transformed Refrigerants into the Largest and Most Profitable in The Linde Group • Transformed Specialty Gases to be the 2nd Largest in The Linde Group • Doubled Helium Turnover while maintaining The Linde Group’s Highest % Margin • Delivered > 80% of the Region’s Price Gains 2010-2015, consistently achieving > 100% Price-Cost Recovery  Key Roles in M&A Integration Teams that ensured Realization of Full Synergetic Potential  Formed Strategic Partnerships with Major Multinationals including GE, Siemens, Phillips, Honeywell & Dupont  Delivered Supply Chain Transformation • Fast 1-to-6-Year Investment Paybacks • up to 40% Cost of Goods Reductions • up to 50% Lead Time Reductions, & • an Operationally Excellent Product and Service Offer

  • South Pacific Business Manager, Specialty Gases & Helium at BOC South Pacific
    1999 - 2005 · 6 yrs

    BOC Gases was one of the world’s most respected brands and the most global industrial gases company with over 1200 operating sites in 60 countries with sales totaling $14 billion p.a. In Australia, BOC is the clear market leader in its field with over 300,000 customers and 25,000 products resulting in sales exceeding $2 billion p.a. Reporting the General Manager, Key Responsibilities included; - Setting the Business Vision, Direction & Strategy of the Specialty Gases & Helium Businesses - Preparing and Delivering Stretching Sales & Profit Budgets - Developing, Implementing & Communicating Product & Service Offers that Generate Value - Developing & Maintaining a Safe, Non-Discriminating and Motivating Work Environment including a Team Culture which Values Accountability, Transparency, Collaboration and Stretching Targets. - Ensuring the Delivery of Uncompromised Service through the Definition and Implementation of Best Operating Practices in Core Functional Groups including Production, Distribution & Customer Service Key Achievements  Consistently Delivered & Exceeded Stretching Sales Plans ($100m) with > 8% p.a Sales & Profit Growth  Introduced Best Commercial Practices that Yielded Significant Revenue Streams, Margin Improvements & Price Stick  Developed Pricing Strategy for Helium Merchant Contracts Yielding > $3.0 million p.a. Margin Improvement  Led Cross-Functional Teams to Develop Customer Facing Business Processes that Formed the Basis of Best Operating Practice and Service Excellence  Implemented & Measured Operational KPI’s Aligned to Business Goals for Greater Visibility, Transparency & Control, Raising Delivery Precision from initial Lows of 40% to Operationally Excellent Levels well over 90%  Member of Global Steering Team Responsible for Strategy and BOC Scientific Brand Creation and Global Roll-Out

  • International Business Development Manager at GBC Scientific Equipment
    1992 - 1999 · 7 yrs

    Australian manufacturer of leading-edge instrumentation, GBC exports 90% of its products through its network of over 100 distributors in 70 countries worldwide. Reporting to the Owner/CEO/Founder, Key Responsibilities included: - Driving New Product Development from Conception, through R&D and Commercialization - Delivering Aggressive Sales Budgets - Marketing Communications & Promotional Planning - Distributor Sales Channel Performance including opening New Geographies, Training, Pre- & Post-Sales Support Key Achievements  Spearheaded the Development and Launch of GBC’s most sophisticated Technology, its first Inductively Coupled Plasma Optical Emission Spectrometer (ICP-OES)  Built an Installation Base in over 40 countries, including into Premium Accounts such as Shell, Mobil, SmithKline Beecham, DuPont and Samsung, in less than 5 years  Grew Sales Revenues to GBC’s from Zero to Second Largest of 5 Product Lines despite Economic Turmoil, Industry Consolidation & overall Declining Organizational Performance  Received ICI’s TECHNICAL INNOVATION Award for Integra ICP-OES Conceptualization

  • Senior Product Manager at Varian, Inc. (Now Agilent)
    1987 - 1992 · 5 yrs

    Australian subsidiary of the multi-national American company Varian, Varian Australia was the market leading global brand in the manufacture of high technology instrumentation. Since acquired by Agilent. Reporting to the Marketing Manager, responsibilities included: - Preparation of New Product Hardware & Software Specifications, including User Interface Layout & Design - Preparation of Wide-Ranging Marketing Materials including Promotional brochures, Sales Manuals, Application Books, Seminar Presentations & Technical Papers - Development of Customer & Sales Training Materials & Programs, and - Conducting Customer Demonstrations. Key Achievements  Spearheaded the Development and Launch of Cutting-Edge Instrumentation including Varian’s first (ICP-OES) which remains Market Leader to this Day  Trained over 1000 sales people throughout the USA and Europe  Awarded Varian’s Prestigious EXCELLENCE AWARD for Most Successful Product Launch that Set New Standards for Future Launches